In KwaZulu-Natal province, our project’s community-oriented approach is to increase integrated HIV testing and TB screening, as well as access and adherence to HIV treatment.
The Khayelitsha project near Cape Town continues to develop and implement treatment regimens for MDR-TB and innovative models of care for patients living with HIV and TB.
Our teams are currently responding to the coronavirus COVID-19 pandemic in South Africa.
Our activities in 2020 in South Africa
Data and information from the International Activity Report 2020.
To address the secondary consequences of COVID-19, which included a sharp decline in the uptake of health services, we adapted our existing activities in novel ways. Our sexual violence project in South Africa’s platinum belt ensured that health services for victims remained accessible through the provision of phone-based counselling and transport at a time when public services had ceased.
Our teams in Eshowe and Khayelitsha worked to maintain HIV and TB diagnosis and treatment through large-scale distribution of oral HIV self-testing kits, and by making sure that local facilities tested for COVID-19, HIV and TB at the same time. Staff delivered antiretrovirals (ARV) and medications for other chronic diseases to patients’ homes or community pick-up points, and provided home-based care for drug-resistant TB (DR-TB) patients.
Our teams worked in numerous shelters for homeless people in the cities of Tshwane and Johannesburg, delivering mental health and medical services, which in Tshwane included the distribution of opioid substitution therapy. During the first COVID-19 wave, we set up, staffed and managed a 60-bed COVID-19 field hospital in a sports hall in Khayelitsha, treating patients with moderate-to-severe COVID-19 in their community. In the second wave, we supported COVID-19 wards in seven hospitals in three provinces.
In 2020, MSF celebrated 20 consecutive years of operations, with milestones including the development of the first ARV treatment programmes on the continent and a successful push for shorter, less toxic treatment for DR-TB.
AIDS death toll stagnating due to lack of testing at community level
MSF report "No time to lose" examines the fight against AIDS in 15 countries
TB drug delamanid must be more affordable and made available in more countries
Drivers for victims: changing lives in Rustenburg
HIV project in South Africa reaches 90-90-90 target one year ahead of deadline
Critical gaps in mental healthcare for survivors of sexual violence
The mental healthcare lottery faced by victims of sexual violence
Country takes landmark step for access to medicines
Responding to pervasive sexual violence in the platinum belt
7th Floor, Zurich House
70 Fox Street, Marshalltown